These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15215611)

  • 1. Inhibition of osteoporosis induced by protein deficient (PD) food intake by active vitamin D(3) and vitamin K(2) in rats.
    Sun L; Tamaki H; Ohta Y; Katsuyama N; Ishimaru T; Chinen I
    Biosci Biotechnol Biochem; 2004 Jun; 68(6):1385-7. PubMed ID: 15215611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Running inhibits osteoporosis induced by protein-deficient (PD) food intake.
    Tamaki H; Sun L; Ohta Y; Katsuyama N; Ishimaru T; Chinen I
    Biosci Biotechnol Biochem; 2004 Jul; 68(7):1578-80. PubMed ID: 15277765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low protein intake magnifies detrimental effects of ovariectomy and vitamin D on bone.
    Marotte C; Gonzales Chaves MM; Pellegrini GG; Friedman SM; Lifshitz F; Mandalunis P; Zeni SN
    Calcif Tissue Int; 2013 Aug; 93(2):184-92. PubMed ID: 23708885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis.
    Shiraishi A; Higashi S; Masaki T; Saito M; Ito M; Ikeda S; Nakamura T
    Calcif Tissue Int; 2002 Jul; 71(1):69-79. PubMed ID: 12073154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of controlled zinc release on bone mineral density from injectable Zn-containing beta-tricalcium phosphate suspension in zinc-deficient diseased rats.
    Otsuka M; Ohshita Y; Marunaka S; Matsuda Y; Ito A; Ichinose N; Otsuka K; Higuchi WI
    J Biomed Mater Res A; 2004 Jun; 69(3):552-60. PubMed ID: 15127402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concurrent treatment of osteoporosis including vitamin K].
    Kobayashi S; Shiraki M; Takaoka K
    Clin Calcium; 2007 Nov; 17(11):1731-7. PubMed ID: 17982194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
    Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of osteoporosis due to restricted food intake by the fish oils DHA and EPA and perilla oil in the rat.
    Sun L; Tamaki H; Ishimaru T; Teruya T; Ohta Y; Katsuyama N; Chinen I
    Biosci Biotechnol Biochem; 2004 Dec; 68(12):2613-5. PubMed ID: 15618634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of primary osteoporosis with vitamin K2].
    Hosoi T
    Clin Calcium; 2007 Nov; 17(11):1727-30. PubMed ID: 17982193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitamin K and osteoporosis].
    Luo LZ; Xu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):346-9. PubMed ID: 12905754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy.
    Kidd PM
    Altern Med Rev; 2010 Sep; 15(3):199-222. PubMed ID: 21155624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.
    Kobayashi M; Hara K; Akiyama Y
    Bone; 2004 Nov; 35(5):1136-43. PubMed ID: 15542039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S
    Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different forms of alkaline phosphatase in adult rat femur. Effect of a vitamin D3-deficient diet and of a sorbitol-enriched diet.
    Tardivel S; Banide H; Porembska Z; Aymard P; Dupuis Y; Lacour B
    Calcif Tissue Int; 1992 May; 50(5):433-8. PubMed ID: 1317741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of glucocorticoid-induced osteoporosis in collagen vascular disease].
    Kawano S; Kumagai S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():504-7. PubMed ID: 18161157
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective evaluation of Vitamin K2, Raloxifene and their co-administration in osteoporotic rats.
    Tasci AG; Bilgili H; Altunay H; Gecit MR; Keskin D
    Eur J Pharm Sci; 2011 Jul; 43(4):270-7. PubMed ID: 21575717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of concurrent therapy for patients with osteoporosis].
    Kobayashi S; Shiraki M; Takaoka K
    Clin Calcium; 2005 Apr; 15(4):661-5. PubMed ID: 15802781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K2: a novel therapy for osteoporosis.
    Prabhoo R; Prabhoo TR
    J Indian Med Assoc; 2010 Apr; 108(4):253-4, 256-8. PubMed ID: 21114195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.